UBS AM’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,109
Closed -$356K 2648
2023
Q2
$356K Hold
6,109
﹤0.01% 2424
2023
Q1
$356K Buy
6,109
+584
+11% +$34.1K ﹤0.01% 2424
2022
Q4
$282K Buy
5,525
+724
+15% +$36.9K ﹤0.01% 2350
2022
Q3
$393K Buy
4,801
+50
+1% +$4.1K ﹤0.01% 2426
2022
Q2
$321K Buy
4,751
+610
+15% +$41.3K ﹤0.01% 2459
2022
Q1
$458K Sell
4,141
-1,974
-32% -$218K ﹤0.01% 2488
2021
Q4
$590K Buy
6,115
+489
+9% +$47.2K ﹤0.01% 2487
2021
Q3
$491K Hold
5,626
﹤0.01% 2510
2021
Q2
$871K Buy
5,626
+1,918
+52% +$297K ﹤0.01% 2278
2021
Q1
$585K Sell
3,708
-484
-12% -$76.4K ﹤0.01% 2330
2020
Q4
$973K Buy
4,192
+841
+25% +$195K ﹤0.01% 2008
2020
Q3
$734K Sell
3,351
-113
-3% -$24.7K ﹤0.01% 1962
2020
Q2
$984K Sell
3,464
-4
-0.1% -$1.14K ﹤0.01% 1819
2020
Q1
$999K Sell
3,468
-877
-20% -$253K ﹤0.01% 1693
2019
Q4
$1.25M Buy
4,345
+736
+20% +$212K ﹤0.01% 1810
2019
Q3
$521K Buy
3,609
+1,811
+101% +$261K ﹤0.01% 2272
2019
Q2
$162K Buy
1,798
+904
+101% +$81.2K ﹤0.01% 2591
2019
Q1
$78.3K Hold
894
﹤0.01% 2582
2018
Q4
$126K Buy
+894
New +$126K ﹤0.01% 2493
2016
Q4
Sell
-700
Closed -$102K 2577
2016
Q3
$102K Hold
700
﹤0.01% 2573
2016
Q2
$70K Hold
700
﹤0.01% 2598
2016
Q1
$94K Hold
700
﹤0.01% 2575
2015
Q4
$139K Hold
700
﹤0.01% 2619
2015
Q3
$111K Hold
700
﹤0.01% 2598
2015
Q2
$286K Sell
700
-6,740
-91% -$2.75M ﹤0.01% 2396
2015
Q1
$3.42M Sell
7,440
-47
-0.6% -$21.6K ﹤0.01% 1154
2014
Q4
$4.2M Buy
7,487
+6,947
+1,286% +$3.9M ﹤0.01% 1081
2014
Q3
$283K Buy
+540
New +$283K ﹤0.01% 2175
2014
Q2
Sell
-3,107
Closed -$1.44M 2569
2014
Q1
$1.44M Sell
3,107
-13
-0.4% -$6.02K ﹤0.01% 1439
2013
Q4
$1.07M Buy
+3,120
New +$1.07M ﹤0.01% 1498